Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    1%
    Check dated 2025-05-01T05:06:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2025-04-23T22:11:50.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Acute Myeloid Leukemia and the EudraCT number, while significant details about a previous study and its criteria have been removed.
    Difference
    13%
    Check dated 2025-04-16T14:33:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.5%
    Check dated 2025-04-09T09:23:45.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-25T14:01:25.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-11T04:36:23.000Z thumbnail image

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.